December 16, 2015 – The tranSMART Foundation today announced that it will manage and further develop the OpenBEL project in an agreement with Selventa. Biological Expression Language (BEL) is a language, developed by Selventa, for representing top scientific findings in a standard way to foster collaboration and sharing of these findings. OpenBEL is a member-based community focused on accelerating the pace of open source technology innovation and scientific discovery.
tranSMART Foundation announces a redesigned and updated wiki with improved integration with the tranSMART Foundation website.
Following the 2015 tranSMART Annual Meeting in Amsterdam, the tranSMART Foundation today released a redesigned wiki with improved navigation and a greater focus on end users. Keith Nangle, tranSMART’s European Community Manager led the project that incorporated suggestions from Members, 3C committees and platform users.
Notable improvements include:
- A completely rewritten procedure for installation of the current version of the tranSMART Platform. Feedback at the Annual Meeting indicated that this was a major barrier to wider adoption and use of the system
- An updated development roadmap through 2017
- A single site to explore data available to the tranSMART community with additional public data sets that are available for loading into your own tranSMART database
- A new location for Use Cases from users of the Platform
- And many updated and new sections!
The tranSMART Foundation 2015 ANNUAL MEETING in Amsterdam opened with a review of the past year and a look to the future for the Foundation by CEO Keith Elliston.
See more on the Annual Meeting and review the slides, posters and presentation recordings on the Annual Meeting Page.
Over 160 registered attendees for the tranSMART Foundation 2015 Annual Meeting are gathered in Amsterdam at the Netherlands Cancer Institute.
The attendees are gathering for the first session.
Gerrit Meier opened the meeting from NKI and CTMM.
Follow the meeting on twitter using #tFAnnual15
The tranSMART Foundation has completed its spring 2015 User Survey. The overall results from the survey have been summarized in a report that has been announced today. The number of organizations using the Platform continues to rise and current users who responded to the survey produce a 5 TIMES increase in their users for 2016.
Wakefield, Massachusetts – August 24, 2015 – The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced its tranSMART v1.2 platform has been selected as a 2015 R&D 100 Award Finalist by R&D Magazine in the Software/Services category. The R&D 100 Award recognizes the 100 most technologically significant products introduced in the past year.
“We are incredibly honored that the tranSMART platform has been selected to be a part of this impressive group of technology products,” said tranSMART Foundation CEO Keith Elliston, PhD. “Our community of scientists and technologists worked hard to develop this version of our open source platform, enabling organizations from around the world to more efficiently and effectively share pre-competitive translational research data with the goal of improving the understanding of well and diseased processes, as well as the discovery of new treatment and diagnostic tools and products.”
Read the Full Release.
The tranSMART Foundation Continues to Expand Membership
Abbvie, BT Global Services, DExStR, IO Informatics, Philips, Rancho Biosciences, and Thomson Reuters Join the Foundation to Help Advance Translational Medicine Research
Wakefield, Massachusetts – August 17, 2015 – The tranSMART Foundation, a non-profit organization providing a global, open-source knowledge management platform for scientists to share pre-competitive translational research data, today announced that seven new life sciences and technology organizations have become members in the first half of 2015. These industry-leading companies join more than two dozen organizations that have not only made substantial financial commitments by joining the Foundation’s Membership Program, but also valued contributions to the tranSMART community, the enhancement of the tranSMART open-source platform and to the advancement of translational medicine research.
In a recent article in CIO Insight, new tranSMART Foundation Silver Member Rancho Biosciences’ CEO Julie Bryant was interviewed about the pharma industry, Rancho and their involvement in tranSMART. Julie also discusses her partnership with another new Foundation Silver Member, British Telecom.
Rancho BioSciences, a provider of data curation services for the pharmaceutical industry, turns to the cloud to deliver model performance. Big data and analytics are at the heart of today’s biosciences and pharmaceutical industries. The ability to crunch numbers and understand complex equations is critical. But building an IT environment that can deliver massive processing power and accommodate storage and other requirements is nothing less than daunting. “There are sometimes terabytes of data to deal with and the ability to process data rapidly and efficiently is extremely important,” said Julie Bryant, CEO at Rancho BioSciences, a San Diego, Calif., firm that handles sophisticated data analysis for genomic and clinical data sets. As a result, Rancho BioSciences has partnered with British Telecom (BT) to deliver a cloud-based IT infrastructure that’s robust enough to address the needs of customers. The infrastructure-as-a-service (IaaS) platform, which incorporates an open-source data analytics platform called tranSmart (managed by the tranSmart Foundation and founded by Johnson & Johnson in 2009) offers an environment that keeps the company at the leading edge of scientific data analysis.
R&D Magazine released its list of Finalists for the 53rd annual R&D 100 Awards, which honor the 100 most innovative technologies and services of the past year. The Press Release is available.
Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market. Widely recognized as the “Oscars of Invention,” the R&D 100 Awards identify and celebrate the top technology products of the year.
The tranSMART Platform v1.2 was named a finalist in the Software/Services category.
This year’s Winners will be presented with their honors at the annual black-tie awards dinner on November 13, 2015 at Caesars Palace, Las Vegas, Nevada as part of its 2015 R&D 100 Awards & Technology Conference on November 12-13, 2015.
San Diego, CA – June 16th, 2015 – Rancho BioSciences, The Data Curation Company, announced it has donated GWAS (Genome Wide Association Studies) ETL (Extract, Transform and Load) scripts and documentation for tranSMART v 1.2 Oracle to Github. Rancho worked in collaboration with two major pharmaceutical companies to make this happen. A script was developed for the latest version of tranSMART which performs indexing for the improved performance of the Genome Wide Association Visual Analyzer (GWAVA), tranSMART’s interactive Manhattan plotter developed by Peter Henstock of Pfizer. With the new scripts, Rancho improved the speed of the search queries so that tranSMART users can quickly and easily get the information they need.